Dogwood TherapeuticsDWTX
13F holders, Q2 2025 (June 30)10holders −3
1new positions
4sold out
$4.80avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, down 3 from Q1 2025. 1 opened new positions and 4 sold out. The largest holders were Morgan Stanley ($83K), Geode Capital Management, LLC ($62K) and Vanguard Group Inc. ($57K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $114 |
| Exits | 4 | $269K |
All 13F filers, Q1 2025 → Q2 2025: 16,881 shares bought and 55,650 shares sold, net −38,769 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Morgan Stanley | 0.00% | Add +2808.3% | 17,450 | $83K |
| Geode Capital Management, LLC | 0.00% | Reduce -11.0% | 12,823 | $62K |
| Vanguard Group Inc. | 0.00% | No change | 11,782 | $57K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -24.6% | 792 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -18.6% | 153 | $730 |
| Activest Wealth Management | 0.00% | No change | 120 | $572 |
| BlackRock, Inc. | 0.00% | No change | 30 | $143 |
| Raymond James Financial Inc. | 0.00% | New | 24 | $114 |
| Bank of America Corp. | 0.00% | Add +70.0% | 17 | $81 |
| Group One Trading LLC | 0.00% | No change | 9 | $43 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.